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Abstract
Carcinoid tumours of the common bile duct represent an extremely rare entity. Similarly, primary follicular
lymphomas of the ampulla of Vater constitute an infrequent neoplasia. Herein, we report the first case of a
synchronous development of a carcinoid tumour of the common bile duct and an ampullary follicular lymphoma
that was treated surgically with a Whipple’s procedure, due to inability to establish definitive preoperative
diagnosis despite the extensive diagnostic investigation.
Background
Carcinoid tumours of the extrahepatic bile duct (EHBD)
represent extremely rare lesions. These neoplasms
account for 0.1% to 0.3% of all gastrointestinal carcinoid
tumours [1]. Unlike cholangiocarcinomas, bile duct car-
cinoids occur more commonly in younger patients and
in women [2]. Altogether, 70 patients with carcinoid
tumours arising from the biliary tree have been reported
in the literature [3]. Similarly, follicular lymphomas of
the ampulla of Vater represent an infrequent entity
accounting for only 1-3.8% of all gastrointestinal lym-
phomas [4] with only a few cases reported in the litera-
ture [4,5]. Interestingly, these cases most commonly
occured in women. We report the first case of a syn-
chronous carcinoid tumour of the EHBD and an ampul-
lary follicular lymphoma that was treated surgically.
Case Presentation
A 43-year old Caucasian male with no remarkable
medical history, was referred to our clinic with inter-
mittent jaundice and a 1-month history of nausea,
vomiting, pruritus, dark urine, clay-colored stools and
weight loss of 5 kg. The patient did not report abdom-
inal pain or decreased appetite.
On admission, the patient’s liver function tests (LFTs)
were abnormal; aspartate aminotransferase (AST) 78 IU/
L (normal, < 45 IU/L), alanine aminotransferase (ALT)
109 IU/L (normal, < 45 IU/L), alkaline phosphatase
(ALP) 226 IU/L (normal, 40-150 IU/L), g-glutamyl
transpeptidase (gGT) 932 IU/L (normal, 10-55 IU/L),
total bilirubin 1.3 mg/dl (normal, 0.21-1.2 mg/dl) and
direct bilirubin 0.9 mg/dl (normal, < 0.5 mg/dl), while
the tumour markers CEA, CA 19-9 and AFP were
within normal range.
Contrast enhanced computed tomography (CT) of the
abdomen revealed dilatation of the biliary tree, with the
hepatic duct measuring a diameter of 1.8 cm. Neither
lymph node enlargement nor splenomegaly was demon-
strated. Magnetic resonance cholangiopancreatography
(MRCP) showed dilated intrahepatic and extrahepatic
bile ducts including the cystic duct and the gallbladder.
The common bile duct (CBD) measured 1.4 cm in dia-
meter with an abrupt concentric stenosis in its lower
third and a cut-off point located 1 cm distally to the
duodenal ampulla. The pancreatic duct was depicted as
normal (Figure 1).
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duodenal ampulla of Vater thickened and the CBD
dilated with the presence of thick content.
The patient underwent an endoscopic retrograde cho-
langiopancreatography (ERCP). The ampulla of Vater
was depicted as being infiltrated by the neoplasm. An
endoscopic sphincterotomy was carried out, thus letting
us better view and sample the region, and the biopsies
taken revealed the presence of an undifferentiated neo-
plasm, but no definitive diagnosis was made.
Taking into consideration the aforementioned find-
ings, our decision was to operate on the patient, and we
performed a pylorus-preserving pancreaticoduodenect-
omy with the en bloc resection of the area in question
and surrounding structures, including the regional
lymph nodes.
Histopathological and immunohistochemical study of
the surgical specimen revealed infiltration of the duode-
num by a non-Hodgkin B cell lymphoma, predominantly
of nodular type, with characteristics of grade I follicular
lymphoma [World Health Organization (WHO) classifi-
cation] with G(l)+ clonicity and indicative immunohis-
tochemical examination (CD 10+, bcl-2-) (Figure 2). In
addition, an intramucosal carcinoid of the CBD, measur-
ing a diameter of 0.3 cm, was identified. All eight
excised lymph nodes were normal (Figure 3).
Postoperatively, the patient was further staged.
Regarding the lymphoma, we conducted a CT scan of
the neck and chest as well as a bone marrow biopsy to
exclude extra-enteric lesions, and we proceeded with a
video capsule endoscopy in order to exclude multifocal
involvement of the small intestine [6]. All these addi-
tional exams yielded no findings. As far as the carcinoid
was concerned, the levels of the neuroendocrine mar-
kers 5-HIAA (5-hydroxyindoleacetic acid), CgA (chro-
mogranin A) and NSE (neuron-specific enolase) were
found within normal range. Because of the small size
and histology of the carcinoid, no other imaging modal-
ities such as Octreoscan or MIBG (meta-iodobenzylgua-
nidine) scintigraphy were used [7].
The follow-up of the patient includes a complete
blood count, routine biochemical exams and an abdom-
inal CT scan every six months after surgery, supported
with an annual evaluation of CgA levels [6,7]. Eighteen
months after the resection, neither the lab tests nor the
imaging techniques have revealed any recurrence of the
disease nor has the patient referred any symptoms.
Figure 1 MRCP depicting the dilatation and abrupt stenosis of
the CBD, close to the ampulla of Vater (arrow).
Figure 2 Histological section of the duodenum showing a
lymphoproliferative lesion consistent with a non-Hodgkin
lymphoma (Hematoxylin & Eosin, ×250).
Figure 3 Histological section of Vater’s ampulla showing a
carcinoid with insular pattern (H&E, ×250).
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Carcinoid tumours arise from enterochromaffin cells,
also known as argentaffin or Kulchitsky cells. The term
enterochromaffin refers to the ability to stain with
potassium chromate (chromaffin), a feature of cells that
contain serotonin. These cells are located in the gastro-
intestinal tract (most commonly in the small intestine,
appendix and rectum) [1] or at various sites within the
respiratory tract [8] or the pelvic cavity (uterine cervix,
ovary, testis), the oto-laryngeal region and the breast [9].
A small number of these cells also exist in the biliary
tree [10]. The rarity of carcinoid tumours in this region
a r ep r o b a b l ye x p l a i n e db yt h ev e r yl i m i t e dn u m b e ro f
the Kulchitsky cells [11]. Carcinoid tumours of the
EHBD account for only 0.1-0.3 of all gastrointestinal
carcinoids [1].
The term ‘carcinoid tumour’ has been replaced by the
term ‘well-differentiated endocrine tumour’ in the latest
WHO classification of tumours (IARC, Lyons, France,
2000). The malignancy of neuroendocrine tumours is
well described, ranging from well-differentiated tumours
to malignant neoplasms [1,12].
The WHO staging system is based on the criteria such
as tumour size, histological differentiation, Ki-67 immu-
nostaining, invasion of adjacent tissues, and vascular
and perineural invasion.
Available data extrapolated from the existing literature
suggest that carcinoid tumours of the extrahepatic bili-
ary tree are of low malignancy [13]. However, these neo-
plasms tend to metastasize if remain untreated [9].
Complete resection of localized tumours, without metas-
tases, results in a 5-year survival of 60-100% [1,14] thus
proposing aggressive surgical management as an optimal
treatment modality. In contrast, radiotherapy offers no
benefit and chemotherapy has been used only in metas-
tastic disease with too few reports to support any defini-
tive conclusions [15].
Primary gastrointestinal non-Hodgkin lymphomas
( N H L )c o n s t i t u t em o r et h a no n e - t h i r do fa l le x t r a n o d a l
lymphomas. The stomach is the most common site, fol-
lowed by the colorectal region and the terminal ileum
[16]. The duodenum is less frequently affected. The vast
majority (80-90%) of primary gastrointestinal lympho-
mas originate from B cells and include diffuse large B
cell lymphoma (DLBCL) and mucosa-associated lym-
phoid tissue (MALT) lymphoma, whereas follicular lym-
phomas have a reported incidence of 1-3.8% [4].
Compared to other biliary malignancies, lymphomas
are more sensitive to chemotherapy and radiotherapy.
However, NHLs represent a rare cause of malignant bili-
ary obstruction, accounting for 1-2% of all cases [17],
thus making medical decision-making a challenging pro-
cedure. Lymphomas of the periampullary region causing
obstructive jaundice could be treated with chemotherapy
provided that biliary drainage has been established
securely through stenting of the CBD. Carcinoid
tumours of the EHBD and ampullary follicular lympho-
mas, constitute exceedingly rare neoplasms. We herein
report the first case of a synchronous development of
these two malignancies that was treated surgically.
Unlike most cases in the literature, where both
carcinoids and follicular lymphomas exhibited a female
predominance, our case refers to a 43-year-old male.
A l t h o u g ht h er o l eo fs u r g e r yf o rg a s t r o i n t e s t i n a l
lymphomas is not the treatment of choice, in our case
resection was obligatory since the endoscopic biopsies
were inconclusive.
Conclusion
We present a patient harbouring a periampullary neo-
plasm, causing obstructive jaundice. We proceeded with
a pancreaticoduodenectomy based on the preoperative
finding of a poorly undifferentiated periampullary neo-
plasm. However, the final diagnosis revealed a follicular
lymphoma of the duodenum and a carcinoid tumour of
the CBD. No adjuvant therapy was judged appropriate
after thorough staging and the patient is doing well
eighteen months after surgery.
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